Most Popular

1
IMF lowers Korea's 2025 growth outlook to 2%
2
Labor Ministry dismisses Hanni harassment case
3
Reality show 'I Live Alone' disciplined for 'glorifying' alcohol consumption
4
North Korean troops fighting alongside Russia, NIS confirms
5
Now is no time to add pressure on businesses: top executives

6
CJ CheilJedang to spur overseas growth with new Hungary, US plants
7
Japan to hold 1st memorial for Korean forced labor victims at Sado mine
8
[Herald Interview] How Gopizza got big in India
9
[KH Explains] Dissecting Hyundai Motor's lobbying in US
10
Nearly half of pines at Seoraksan face extinction due to global warming: study

NewsletterSubscribe

Start your day with a roundup of key stories from The Korea Herald with news and comment on all that’s happening in Korea.

Hanmi Pharma’s Q3 operating income down 61.5% to W13.5b

By 황유미

Published : Oct. 27, 2016 - 09:06

- Link copied

[DISCLOSURE] Hanmi Pharmaceutical (128940) reported on Oct. 27 that its operating profit in the third quarter slumped 61.5 percent to 13.7 billion won (US$12.03 million) on-year.

The revenue fell 18.1 percent to 219.7 billion won and net profit turned to black at 6.3 billion won from the same period last year.

(theinvestor@heraldcorp.com)

Hanmi Pharma’s Q3 operating income down 61.5% to W13.5b

More from Headlines